These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Biodiversity, chemical diversity and drug discovery. Singh SB; Pelaez F Prog Drug Res; 2008; 65():141, 143-74. PubMed ID: 18084915 [TBL] [Abstract][Full Text] [Related]
9. A Review of the Microbial Production of Bioactive Natural Products and Biologics. Pham JV; Yilma MA; Feliz A; Majid MT; Maffetone N; Walker JR; Kim E; Cho HJ; Reynolds JM; Song MC; Park SR; Yoon YJ Front Microbiol; 2019; 10():1404. PubMed ID: 31281299 [TBL] [Abstract][Full Text] [Related]
10. Genome Mining as New Challenge in Natural Products Discovery. Albarano L; Esposito R; Ruocco N; Costantini M Mar Drugs; 2020 Apr; 18(4):. PubMed ID: 32283638 [TBL] [Abstract][Full Text] [Related]
11. Using natural products for drug discovery: the impact of the genomics era. Zhang MM; Qiao Y; Ang EL; Zhao H Expert Opin Drug Discov; 2017 May; 12(5):475-487. PubMed ID: 28277838 [TBL] [Abstract][Full Text] [Related]
12. The expanding spectrum of diketopiperazine natural product biosynthetic pathways containing cyclodipeptide synthases. Borgman P; Lopez RD; Lane AL Org Biomol Chem; 2019 Feb; 17(9):2305-2314. PubMed ID: 30688950 [TBL] [Abstract][Full Text] [Related]
13. Strategies to access biosynthetic novelty in bacterial genomes for drug discovery. Hemmerling F; Piel J Nat Rev Drug Discov; 2022 May; 21(5):359-378. PubMed ID: 35296832 [TBL] [Abstract][Full Text] [Related]
14. Heterologous expression of bacterial natural product biosynthetic pathways. Huo L; Hug JJ; Fu C; Bian X; Zhang Y; Müller R Nat Prod Rep; 2019 Oct; 36(10):1412-1436. PubMed ID: 30620035 [TBL] [Abstract][Full Text] [Related]
15. Natural products and Pharma 2011: strategic changes spur new opportunities. Carter GT Nat Prod Rep; 2011 Oct; 28(11):1783-9. PubMed ID: 21909580 [TBL] [Abstract][Full Text] [Related]
16. Deciphering mechanisms of production of natural compounds using inducer-producer microbial consortia. Gasparek M; Steel H; Papachristodoulou A Biotechnol Adv; 2023; 64():108117. PubMed ID: 36813010 [TBL] [Abstract][Full Text] [Related]
17. Microbial chassis engineering drives heterologous production of complex secondary metabolites. Liu J; Wang X; Dai G; Zhang Y; Bian X Biotechnol Adv; 2022 Oct; 59():107966. PubMed ID: 35487394 [TBL] [Abstract][Full Text] [Related]
18. Detection of antibacterial-like activity on a silica surface: fluoroquinolones and their environmental metabolites. Lewis G; Juhasz A; Smith E Environ Sci Pollut Res Int; 2011 Aug; 19(7):2795-801. PubMed ID: 22311580 [TBL] [Abstract][Full Text] [Related]